Metraipolis › archive › dc_e35d77fe9b06
Effect of angiotensin II receptor blockers on efficacy and safety of Camrelizumab plus chemotherapy in the first-line therapy for advanced non-small cell lung… — Europe PMC PMID:41306970
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41306970
- DOI
- 10.3389/fimmu.2025.1668782
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T16:17:45.151Z
- SHA-256 of the archived text
1d66ca260b5a5e8002d11e11909fbdecd5227ca71c517ec7973dab8d2cf86c02- Stable URL of this page
https://metraipolis.com/documento/dc_e35d77fe9b06
How to cite
Effect of angiotensin II receptor blockers on efficacy and safety of Camrelizumab plus chemotherapy in the first-line therapy for advanced non-small cell lung… — Europe PMC PMID:41306970 — Europe PMC (en), https://europepmc.org/article/MED/41306970 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e35d77fe9b06 (Metraipolis archive dc_e35d77fe9b06, sha256 1d66ca260b5a5e8002d11e11909fbdecd5227ca71c517ec7973dab8d2cf86c02)
BibTeX
@misc{dce35d77fe9b06,
title = {Effect of angiotensin II receptor blockers on efficacy and safety of Camrelizumab plus chemotherapy in the first-line therapy for advanced non-small cell lung… — Europe PMC PMID:41306970},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41306970},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e35d77fe9b06; sha256 1d66ca260b5a5e8002d11e11909fbdecd5227ca71c517ec7973dab8d2cf86c02},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41306970. Agents can read the archived copy with the MCP tool read_document.